<?xml version='1.0' encoding='utf-8'?>
<document id="26463904"><sentence text="[Nalmefene and Opioid Withdrawal Syndrome: Analysis of the Global Pharmacovigilance Database for Adverse Drug Reactions]."><entity charOffset="0-10" id="DDI-PubMed.26463904.s1.e0" text="[Nalmefene" /></sentence><sentence text="Nalmefene (SelincroÂ®) is a selective opioid receptor antagonist, licensed in April 2014 in Switzerland for the reduction of alcohol consumption in adults with a high drinking risk level"><entity charOffset="0-9" id="DDI-PubMed.26463904.s2.e0" text="Nalmefene" /><entity charOffset="37-43" id="DDI-PubMed.26463904.s2.e1" text="opioid" /><entity charOffset="124-131" id="DDI-PubMed.26463904.s2.e2" text="alcohol" /><pair ddi="false" e1="DDI-PubMed.26463904.s2.e0" e2="DDI-PubMed.26463904.s2.e0" /><pair ddi="false" e1="DDI-PubMed.26463904.s2.e0" e2="DDI-PubMed.26463904.s2.e1" /><pair ddi="false" e1="DDI-PubMed.26463904.s2.e0" e2="DDI-PubMed.26463904.s2.e2" /><pair ddi="false" e1="DDI-PubMed.26463904.s2.e1" e2="DDI-PubMed.26463904.s2.e1" /><pair ddi="false" e1="DDI-PubMed.26463904.s2.e1" e2="DDI-PubMed.26463904.s2.e2" /></sentence><sentence text=" 200 reports of adverse drug reactions of nalmefene have been documented worldwide in the WHO global pharmacovigilance database between 7th March 1997 to 1st March 2015"><entity charOffset="42-51" id="DDI-PubMed.26463904.s3.e0" text="nalmefene" /></sentence><sentence text=" In 21 cases (10,5%) nalmefene and an opioid were administered concomitantly, causing withdrawal symptoms"><entity charOffset="21-30" id="DDI-PubMed.26463904.s4.e0" text="nalmefene" /><entity charOffset="38-44" id="DDI-PubMed.26463904.s4.e1" text="opioid" /><pair ddi="false" e1="DDI-PubMed.26463904.s4.e0" e2="DDI-PubMed.26463904.s4.e0" /><pair ddi="false" e1="DDI-PubMed.26463904.s4.e0" e2="DDI-PubMed.26463904.s4.e1" /></sentence><sentence text=" Until now, the regional pharmacovigilance center in Zurich received four cases of nalmefene combined with opioids"><entity charOffset="83-92" id="DDI-PubMed.26463904.s5.e0" text="nalmefene" /></sentence><sentence text=" This combination should be avoided" /><sentence text="" /></document>